Primary Mediastinal Large B Cell Lymphoma

Oncology·MeSH: Leukemia, Lymphocytic, Chronic, B-Cell

Prevalence

56.0 / 100K

Incidence

19.6 / 100K/yr

0 drugs in development·0 companies·5 clinical trials

Frequently asked questions

How many clinical trials target Primary Mediastinal Large B Cell Lymphoma?

There are 5 clinical trials targeting Primary Mediastinal Large B Cell Lymphoma tracked by BioSniper.

What is the prevalence of Primary Mediastinal Large B Cell Lymphoma?

The estimated prevalence of Primary Mediastinal Large B Cell Lymphoma is approximately 56.0 per 100,000 population.

Deep-dive into Primary Mediastinal Large B Cell Lymphoma

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Primary Mediastinal Large B Cell Lymphoma — Drugs in Development & Clinical Trials | BioSniper